Synthgene News丨Jiangsu Provincial Food and Drug Administration Director Tian Feng investigates Synthgene

On the second day after the approval of Synthgene's SARS-CoV-2 antigen reagent, Director Tian Feng of the Provincial Food and Drug Administration led a team to Synthgene. for investigation. Chang Tongkun and others accompanied them to participate in the investigation.

2022

Synthgene Medical| Home self-test OTC hot hits are coming!

On April 1, 2022, SARS-CoV-2 (2019-nCoV) antigen detection kit (colloidal gold) developed by Nanjing Synthgene Technology Co., Ltd. (“ Synthgene”), a wholly-owned subsidiary of Jiangsu Synthgene Biotechnology Co., Ltd. Law) obtained the "Medical Device Registration Certificate" issued by the National Medical Products Administration (NMPA).

2022

Blockbuster丨SARS-CoV-2's antigen detection reagent was successfully approved in China!

On April 1, 2022, the novel coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) developed by Nanjing Synthgene Medical Technology Co., Ltd. was approved by the State Food and Drug Administration (Registration Certificate No.: National Machinery Note 20223400427) and officially launched. Contribute to the rapid screening of the SARS-CoV-2 and the fight against the SARS-CoV-2 epidemic!

2022

Industry News丨Experts "high-profile delivery" SARS-CoV-2 home self-test, Synthgene OTC products are complete!

Since the outbreak of the epidemic, due to the better control of the epidemic than other countries in the world, the nucleic acid detection capacity basically meets the detection needs. my country mainly implements epidemic prevention measures with nucleic acid detection as the main method. Antibody and antigen detection are only used as auxiliary detection methods in a small area. application. European and American countries mainly adopt the epidemic prevention method of COVID-19 antigen home testing, so many domestic IVD companies have received orders from overseas for COVID-19 antigen home testing reagents.

2022

CACLP丨 Synthgene invites you to "prosper" to enjoy the diagnosis ceremony together!

From March 27th to 29th, 2022, Synthgene will participate in the 19th China International Medical and Blood Transfusion Instrument and Reagent Expo (CACLP) held in Nanchang International Expo Center.

2022

< 1 2 3 4 5 6 >

Nanjing Synthgene Medical Technology Co., Ltd.

Nanjing Synthgene Medical Technology Co., Ltd. is a biomedical high-tech enterprise focusing on the development and production of OTC home self-inspection products. The company has a mature technology platform, including chromatography platform, isothermal amplification platform, etc.

Address：Building B6-2, No. 9, Weidi Road, Xianlin University Town, Xianlin Subdistrict, Qixia District, Nanjing City, China
Tel: +86(025)83696681 (overseas)
Email: sales@syngenebio.com
After-sale Email ： service@syngenebio.com

Public Account

Nanjing Synthgene Medical Technology Co., Ltd.

Messages

Tel

+86(025)83696681

E-mail

TOP